News Releases

NEW YORK, Nov.19, 2009 – The New York Stock Exchange (NYSE), a unit of NYSE Euronext (NYX), today announced that Monday, Nov. 30, 2009 will be a Floor Brokers Charity Trading Day—a new endeavor that will unite customers, brokers and the Exchange for the purpose of helping children battling cancer and other deadly diseases at St. Jude Children’s Research Hospital^®, one of the world’s premier pediatric cancer research centers.   NYSE Euronext will donate to St. Jude Children’s Research Hospital all of its net transaction fees for orders that day by floor brokers in NYSE and NYSE Amex securities.

“The NYSE community is proud to support St. Jude’s efforts to treat seriously ill children,” said Joseph Mecane, Executive Vice President of NYSE Euronext.  “The generosity and enthusiasm of the NYSE trading floor community further complements the many other charitable and volunteer efforts of NYSE Euronext markets.”

NYSE floor brokers are part of an Exchange community with a strong and longstanding commitment to charitable causes, including very strong participation in the St. Jude “Taste of New York” event, which occurred on Nov. 12.  As the holiday season approaches, NYSE Euronext views this program as an opportunity to give back and turn our attention to helping some of the sickest children in the world at St. Jude.

About St. Jude Children’s Research Hospital
St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with cancer and other catastrophic diseases. St. Jude is the first and only pediatric cancer center to be designated as a Comprehensive Cancer Center by the National Cancer Institute. Founded by the late entertainer Danny Thomas and based in Memphis , Tenn. , St. Jude freely shares its discoveries with scientific and medical communities around the world. St. Jude is the only pediatric cancer research center where families never pay for treatments not covered by insurance. No child is ever denied treatment because of the family’s inability to pay. St. Jude is financially supported by ALSAC, its fundraising organization. For more information, please visit www.stjude.org

About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies.  The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products.  With more than 8,000 listed issues, NYSE Euronext's equities markets -- the New York Stock Exchange, NYSE Euronext, NYSE Amex and NYSE Alternext as well as NYSE Arca – represent nearly 40 percent of the world's equities trading, the most liquidity of any global exchange group.  NYSE Euronext also operates NYSE Liffe, the leading European derivatives business and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies.  NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100  index and Fortune 500.  For more information, please visit:http://www.nyx.com.

Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext’s plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext’s results to differ materially from current expectations include, but are not limited to: NYSE Euronext’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext’s reference document for 2008 (“document de référence”) filed with the French Autorité des Marchés Financiers (Registered on April 28, 2009 under No. R. 09-031), 2008 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.